ConquerX is a company whose Ebegen technology represents an approach to cancer diagnostics and screening by leveraging a new class of biomarkers - microRNAs - to earlier detect up to eighteen types of cancer in one simple, cost-effective blood test.
Company (Alive / Active)
21 Drydock Avenue, 610E
Massachusetts, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)